Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.55 |
| ▸ | CCR1 | P32246 | 5/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | CCR5 | P51681 | 3/20 | 0.55 |
| ▸ | CCR8 | P51685 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | MMP2 | P08253 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | GMNN | O75496 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | MMP8 | P22894 | 1/20 | 0.55 |
| ▸ | THPO | P40225 | 1/20 | 0.55 |
| ▸ | MTOR | P42345 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16681812 | 0.85 | CCR1 (0.50) | CCR1CCR5SMN1; SMN2TSHRTP53 | |
| SCHEMBL810237 | 0.83 | CCR1 (0.55) | LMNACCR1MAPTCCR5CCR8 | |
| SCHEMBL322128 | 0.81 | LMNA (0.56) | LMNACCR1MAPTCCR5CCR8 | |
| SCHEMBL167042 | 0.81 | ALDH1A1 (0.47) | LMNACCR1MAPTCCR5CCR8 | |
| SCHEMBL10012244 | 0.80 | CCR1 (0.61) | LMNACCR1MAPTCCR5CCR8 | |
| SCHEMBL6886445 | 0.80 | CCR1 (0.52) | LMNACCR1MAPTCCR5CCR8 | |
| Hydrochloric Acid SCHEMBL29113051 | 0.79 | ALDH1A1 (0.46) | LMNACCR1MAPTCCR5CCR8 | |
| Quinoline SCHEMBL11076491 | 0.77 | ALDH1A1 (0.55) | KDM4ESMN1; SMN2TP53CYP3A4HTT | |
| SCHEMBL7555954 | 0.77 | CCR1 (0.69) | LMNACCR1MAPTCCR5CCR8 | |
| SCHEMBL30331100 | 0.77 | CCR1 (0.61) | LMNACCR1MAPTCCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180128767-A1 | Small Volume In Vitro Analyte Sensor | ABBOTT DIABETES CARE INC. (US) | 2018-05-10 | — | — | US | disclosed |
| US-9891185-B2 | Small volume in vitro analyte sensor | ABBOTT DIABETES CARE INC. (US) | 2018-02-13 | — | — | US | disclosed |
| US-20170279146-A1 | Biological Fuel Cell and Methods | E. HELLER & COMPANY | 2017-09-28 | — | — | US | disclosed |
| US-9662057-B2 | Integrated sample acquisition and analyte measurement method | ABBOTT DIABETES CARE INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-9509010-B2 | Biological fuel cell and methods | ABBOTT DIABETES CARE INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160334356-A1 | Small Volume In Vitro Analyte Sensor | THERASENSE, INC. | 2016-11-17 | — | — | US | disclosed |
| US-20160235350-A1 | Integrated Sample Acquisition and Analyte Measurement Device | THERASENSE, INC. | 2016-08-18 | — | — | US | disclosed |
| US-9341591-B2 | Small volume in vitro analyte sensor | ABBOTT DIABETES CARE INC. (US) | 2016-05-17 | — | — | US | disclosed |
| US-9316609-B2 | Small volume in vitro analyte sensor | ABBOTT DIABETES CARE INC. (US) | 2016-04-19 | — | — | US | disclosed |
| US-9291592-B2 | Small volume in vitro analyte sensor | ABBOTT DIABETES CARE INC. (US) | 2016-03-22 | — | — | US | disclosed |
| US-6591125-B1 | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator | THERASENSE, INC. | 2003-07-08 | — | — | US | disclosed |
| US-6531239-B2 | Biological fuel cell and methods | THERASENSE, INC. | 2003-03-11 | — | — | US | disclosed |
| US-6461496-B1 | BLOOD GLUCOSE | THERASENSE, INC. | 2002-10-08 | — | — | US | disclosed |
| US-20020025469-A1 | Anions of equal number to cations to maintain charge neutrality, are disclosed. These spacer groups may be organic or inorganic in origin and may vary in length. The spacer groups may be saturated, containing single bonds, or may have | THERASENSE, INC. | 2002-02-28 | — | — | US | disclosed |
| US-6338790-B1 | DETECTION OF BIOANALYTES IN A SMALL VOLUME SAMPLE; CONCENTRATION OF A BIOMOLECULE, SUCH AS GLUCOSE OR LACTATE, USING TECHNIQUES SUCH AS COULOMETRY, AMPEROMETRY, AND POTENTIOMETRY. AN ENZYME CAPABLE OF CATALYZING THE | THERASENSE, INC. | 2002-01-15 | — | — | US | disclosed |
| CN-1322254-A | Small volume in vitro analytical sensor containing diffusible or non-leachable redox mediator | THERASENSE INC (US) | 2001-11-14 | — | — | CN | disclosed |
| US-6299757-B1 | ANALYTICAL SENSORS FOR THE DETECTION OF BIOANALYTES; ESPECIALLY MONITORING GLUCOSE LEVELS IN DIABETIC PATIENTS | THERASENSE, INC. | 2001-10-09 | — | — | US | disclosed |
| US-6294281-B1 | Biological fuel cell and method | THERASENSE, INC. | 2001-09-25 | — | — | US | disclosed |
| EP-1119637-A1 | SMALL VOLUME $i(IN VITRO) ANALYTE SENSOR WITH DIFFUSIBLE OR NON-LEACHABLE REDOX MEDIATOR | Therasense, Inc. (US) | 2001-08-01 | — | — | EP | disclosed |
| WO-2000020626-A1 | SMALL VOLUME IN VITRO ANALYTE SENSOR WITH DIFFUSIBLE OR NON-LEACHABLE REDOX MEDIATOR | THERASENSE, INC. (US) | 2000-04-13 | — | — | WO | disclosed |